ATAI Deferred Long Term Liab vs Accounts Payable Analysis
| ATAI Stock | USD 1.61 0.09 5.92% |
ATAI Life financial indicator trend analysis is way more than just evaluating ATAI Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ATAI Life Sciences is a good investment. Please check the relationship between ATAI Life Deferred Long Term Liab and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Deferred Long Term Liab vs Accounts Payable
Deferred Long Term Liab vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ATAI Life Sciences Deferred Long Term Liab account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between ATAI Life's Deferred Long Term Liab and Accounts Payable is -0.48. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of ATAI Life Sciences, assuming nothing else is changed. The correlation between historical values of ATAI Life's Deferred Long Term Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of ATAI Life Sciences are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Deferred Long Term Liab i.e., ATAI Life's Deferred Long Term Liab and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.48 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Accounts Payable
An accounting item on the balance sheet that represents ATAI Life obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of ATAI Life Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from ATAI Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ATAI Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. As of now, ATAI Life's Tax Provision is increasing as compared to previous years. The ATAI Life's current Selling General Administrative is estimated to increase to about 68.8 M, while Issuance Of Capital Stock is projected to decrease to 0.00.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 47K | 168K | 319K | 335.0K | Interest Income | 205K | 548K | 1.4M | 1.4M |
ATAI Life fundamental ratios Correlations
Click cells to compare fundamentals
ATAI Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.80) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.54) | Return On Assets (0.25) |
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.